MEG
BMY icon

Millstone Evans Group’s Bristol-Myers Squibb BMY Stock Holding History

Millstone Evans Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$348K Hold
5,743
– – 0.21% 89
2025
Q4 		$310K Sell
5,743
-582
-9% -$28K 0.18% 98
2025
Q3 		$285K Sell
6,325
-26
-0.4% -$1.21K 0.18% 93
2025
Q2 		$294K Buy
6,351
+33
+0.5% +$1.62K 0.2% 93
2025
Q1 		$385K Sell
6,318
-55
-0.9% -$3.21K 0.26% 71
2024
Q4 		$360K Buy
+6,373
New +$356K 0.25% 73

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millstone Evans Group's BMY Position: Q1 2026 in Review

Millstone Evans Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,743 shares worth $348K. The position accounts for 0.21% of the portfolio, ranked #89.

Millstone Evans Group first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $385K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Millstone Evans Group held 5,743 shares of Bristol-Myers Squibb worth $348K as of Q1 2026.
  • Millstone Evans Group left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.21% of Millstone Evans Group's portfolio in Q1 2026, its #89 holding.
  • Millstone Evans Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Millstone Evans Group's Bristol-Myers Squibb position peaked at $385K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Millstone Evans Group's 13F filing for Q1 2026, filed 30 Apr 2026.